Armata Pharmaceuticals, Inc. ( ARMP) - Key Metrics
ARMP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.07 | $2.02 | -$0.24 | -$0.24 |
| 2026Q1 | $0.02 | -$3.16 | -$0.16 | -$0.16 |
| 2025Q4 | $0 | -$3.42 | -$0.18 | -$0.19 |
| 2025Q3 | $0 | -$0.74 | -$0.12 | -$0.13 |
| 2025Q2 | $0.06 | -$0.45 | -$0.20 | -$0.20 |
ARMP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.80 |
| 2026Q1 | 0% | -0.81 |
| 2025Q4 | 0% | -0.46 |
| 2025Q3 | 0% | -1.01 |
| 2025Q2 | 0% | -1.06 |
ARMP
Price: $5.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.36 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 6136
Market Capitalization: 214.4 million